Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viola Donati

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Letters|June 2, 2026
Connexin hemichannels as therapeutic targets in glioblastomaFabio Mammano, Viola Donati, Daniela Marazziti
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 8, 2021
Harnessing the therapeutic potential of antibodies targeting connexin hemichannelsDamiano Buratto, Viola Donati, Francesco Zonta, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2024
Generation of Connexin-Expressing Stable Cell PoolsAbraham Tettey-Matey, Chiara Di Pietro, Viola Donati, et al.
Function (Oxford, England)|March 25, 2022
Calcium Signaling in the Photodamaged Skin: In Vivo Experiments and Mathematical ModelingViola Donati, Chiara Peres, Chiara Nardin, et al.
Cell Communication and Signaling : CCS|December 5, 2024
A fully human IgG1 antibody targeting connexin 32 extracellular domain blocks CMTX1 hemichannel dysfunction in an in vitro modelAbraham Tettey-Matey, Viola Donati, Chiara Cimmino, et al.
International Journal of Molecular Sciences|July 9, 2022
A Quantitative Assay for Ca<sup>2+</sup> Uptake through Normal and Pathological HemichannelsChiara Nardin, Abraham Tettey-Matey, Viola Donati, et al.
Journal of Translational Medicine|May 28, 2026
Antitumor activity of Oncolytic Herpes Symplex Virus Type 1 and photodynamic therapy in in vitro preclinical models of glioblastomaArianna Calistri, Alessandra Rossetto, Alberto Reale, et al.
Cell Communication and Signaling : CCS|September 2, 2025
Connexin hemichannel blockade by abEC1.1 disrupts glioblastoma progression, suppresses invasiveness, and reduces hyperexcitability in preclinical modelsViola Donati, Chiara Di Pietro, Luca Persano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Letters|June 2, 2026
Connexin hemichannels as therapeutic targets in glioblastomaFabio Mammano, Viola Donati, Daniela Marazziti
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 8, 2021
Harnessing the therapeutic potential of antibodies targeting connexin hemichannelsDamiano Buratto, Viola Donati, Francesco Zonta, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 5, 2024
Generation of Connexin-Expressing Stable Cell PoolsAbraham Tettey-Matey, Chiara Di Pietro, Viola Donati, et al.
Function (Oxford, England)|March 25, 2022
Calcium Signaling in the Photodamaged Skin: In Vivo Experiments and Mathematical ModelingViola Donati, Chiara Peres, Chiara Nardin, et al.
Cell Communication and Signaling : CCS|December 5, 2024
A fully human IgG1 antibody targeting connexin 32 extracellular domain blocks CMTX1 hemichannel dysfunction in an in vitro modelAbraham Tettey-Matey, Viola Donati, Chiara Cimmino, et al.
International Journal of Molecular Sciences|July 9, 2022
A Quantitative Assay for Ca<sup>2+</sup> Uptake through Normal and Pathological HemichannelsChiara Nardin, Abraham Tettey-Matey, Viola Donati, et al.
Journal of Translational Medicine|May 28, 2026
Antitumor activity of Oncolytic Herpes Symplex Virus Type 1 and photodynamic therapy in in vitro preclinical models of glioblastomaArianna Calistri, Alessandra Rossetto, Alberto Reale, et al.
Cell Communication and Signaling : CCS|September 2, 2025
Connexin hemichannel blockade by abEC1.1 disrupts glioblastoma progression, suppresses invasiveness, and reduces hyperexcitability in preclinical modelsViola Donati, Chiara Di Pietro, Luca Persano, et al.
Pageof 1